Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Bottom-Up

Inspire Medical Systems Inc / Equity Bottom-Up

<ul><li>Inspire Medical Systems reported a promising third quarter in 2024, demonstrating significant revenue growth and improvements in profitability.</li><li>The company's revenue for the third quarter was $203.2 million, up 33% compared to the same period in 2023.</li><li>This growth was predominantly driven by the increased adoption of Inspire therapy, reflected in the expansion into 66 new implanting centers and growth in 13 new U.S. sales territories.</li></ul>

Inspire Medical Systems reported a promising third quarter in 2024, demonstrating significant revenue growth and improvements in profitability.The company's revenue for the third quarter was $203.2 million, up 33% compared to the same period in 2023.This growth was predominantly driven by the increased adoption of Inspire therapy, reflected in the expansion into 66 new implanting centers and growth in 13 new U.S. sales territories.

Inspire Medical Systems: Is The New Inspire V System A Game Changer? - Major Drivers

<ul><li>Inspire Medical Systems presented its financial results for the second quarter of 2024, displaying substantial growth and positive shifts across its operational and financial spectrums.</li><li>The company, dedicated to advancing medical solutions for obstructive sleep apnea (OSA), has achieved a significant milestone with the treatment of over 75,000 patients using its innovative Inspire therapy.</li><li>Baptista Research looks to evaluate the different factors that could influence the company's price in the near future and attempts to carry out an independent valuation of the company using a Discounted Cash Flow (DCF) methodology.</li></ul>

Inspire Medical Systems presented its financial results for the second quarter of 2024, displaying substantial growth and positive shifts across its operational and financial spectrums.The company, dedicated to advancing medical solutions for obstructive sleep apnea (OSA), has achieved a significant milestone with the treatment of over 75,000 patients using its innovative Inspire therapy.Baptista Research looks to evaluate the different factors that could influence the company's price in the near future and attempts to carry out an independent valuation of the company using a Discounted Cash Flow (DCF) methodology.

Inspire Medical Systems: Expanded Market Penetration Catalyzing Growth! - Major Drivers

<ul><li>Inspired Medical Systems First Quarter 2024 performance showcases a robust growth trajectory alongside strategic market advancements and impending innovations.</li><li>The company reported a notable increase in revenue, which reached $164 million, marking a 28% year-over-year growth.</li><li>This uplift was primarily driven by enhanced penetration in existing markets and expansion into new territories, both domestically and internationally.</li></ul>

Inspired Medical Systems First Quarter 2024 performance showcases a robust growth trajectory alongside strategic market advancements and impending innovations.The company reported a notable increase in revenue, which reached $164 million, marking a 28% year-over-year growth.This uplift was primarily driven by enhanced penetration in existing markets and expansion into new territories, both domestically and internationally.

Inspire Medical Systems Inc.: Expansion in International Markets & 3 Factors Driving Our 'Buy' Rating! - Major Drivers

<ul><li>Inspire Medical Systems, a manufacturer of devices for treating obstructive sleep apnea, recently reported their fourth quarter and full year 2023 financial results.</li><li>The company delivered strong results, noting this was their first quarter with operating income and that they had completed the year on a high note.</li><li>The company reported revenue of $192.5 million for the fourth quarter, a 40% increase from Q4 2020, and net income of $14.8 million, compared to $3.2 million in the prior year.</li></ul>

Inspire Medical Systems, a manufacturer of devices for treating obstructive sleep apnea, recently reported their fourth quarter and full year 2023 financial results.The company delivered strong results, noting this was their first quarter with operating income and that they had completed the year on a high note.The company reported revenue of $192.5 million for the fourth quarter, a 40% increase from Q4 2020, and net income of $14.8 million, compared to $3.2 million in the prior year.

Inspire Medical Systems Inc.: Initiation Of Coverage - Surge in Sleep Center Investments Can Catalyze The Top-Line Growth? - Major Drivers

Fundamental Short Selling Research

Eric Fernandez, CFA

TwoRiversAnalytics

<ul>
<li>Liquidity shorts can be great short candidates.  The key characteristic is that the company may not be viable, economically, given their cash flows and cash requirements. </li>
<li>Liquidity shorts have built-in catalysts, have moderate to higher betas,  and can have strong down moves if a crisis develops.  They can go bankrupt, pushing the stock price near zero.</li>
<li>Today we are flagging Carvana, Exact Sciences, Inspire Med, Freshpet, Enviva .</li>
</ul>


Liquidity shorts can be great short candidates.  The key characteristic is that the company may not be viable, economically, given their cash flows and cash requirements. 
Liquidity shorts have built-in catalysts, have moderate to higher betas,  and can have strong down moves if a crisis develops.  They can go bankrupt, pushing the stock price near zero.
Today we are flagging Carvana, Exact Sciences, Inspire Med, Freshpet, Enviva .


Liquidity Risk Short Candidates: Carvana, Exact Sciences, Inspire Med, Freshpet, Enviva

United States

Inspire Medical Systems, Inc. operates as a medical technology company. The Company develops implantable neurostimulation systems to treat obstructive sleep apnea. Inspire Medical Systems operates in the the United States.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Inspire Medical Systems Inc (INSP US)

Inspire Medical Systems: Is The New Inspire V System A Game Changer? - Major Drivers

Inspire Medical Systems reported a promising third quarter in 2024, demonstrating significant revenue growth and improvements in...

Baptista Research

Inspire Medical Systems: Expanded Market Penetration Catalyzing Growth! - Major Drivers

Inspire Medical Systems presented its financial results for the second quarter of 2024, displaying substantial growth and positive shifts across...

Baptista Research

Inspire Medical Systems Inc.: Expansion in International Markets & 3 Factors Driving Our 'Buy' Rating! - Major Drivers

Inspired Medical Systems First Quarter 2024 performance showcases a robust growth trajectory alongside strategic market advancements and impending...

Baptista Research

Inspire Medical Systems Inc.: Initiation Of Coverage - Surge in Sleep Center Investments Can Catalyze The Top-Line Growth? - Major Drivers

Inspire Medical Systems, a manufacturer of devices for treating obstructive sleep apnea, recently reported their fourth quarter and full year 2023...

Baptista Research

Liquidity Risk Short Candidates: Carvana, Exact Sciences, Inspire Med, Freshpet, Enviva

Liquidity risk short candidates may not be economically viable given cash flows and capital requirements. This week we flag Carvana, Exact...

Eric Fernandez, CFA

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)